IL97827A0 - Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing them - Google Patents
Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing themInfo
- Publication number
- IL97827A0 IL97827A0 IL97827A IL9782791A IL97827A0 IL 97827 A0 IL97827 A0 IL 97827A0 IL 97827 A IL97827 A IL 97827A IL 9782791 A IL9782791 A IL 9782791A IL 97827 A0 IL97827 A0 IL 97827A0
- Authority
- IL
- Israel
- Prior art keywords
- hybridomas
- producing
- production
- monoclonal anti
- igm antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6873—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51597490A | 1990-04-27 | 1990-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL97827A0 true IL97827A0 (en) | 1992-06-21 |
Family
ID=24053580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL97827A IL97827A0 (en) | 1990-04-27 | 1991-04-11 | Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing them |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0538267A4 (en) |
| JP (1) | JPH06504424A (en) |
| CN (1) | CN1057072A (en) |
| CA (1) | CA2079901A1 (en) |
| IE (1) | IE911172A1 (en) |
| IL (1) | IL97827A0 (en) |
| NZ (1) | NZ237784A (en) |
| PT (1) | PT97482B (en) |
| RU (1) | RU2105062C1 (en) |
| TW (1) | TW349995B (en) |
| WO (1) | WO1991017257A1 (en) |
| ZA (1) | ZA912695B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2322562B1 (en) | 2008-09-05 | 2016-03-30 | Sekisui Medical Co., Ltd. | Monoclonal antibody, and immunoassay using same |
| CN108384761B (en) * | 2018-03-30 | 2020-08-11 | 四川迈克生物新材料技术有限公司 | Anti-human IgM monoclonal antibody, hybridoma cell strain and application thereof |
| WO2023088443A1 (en) * | 2021-11-20 | 2023-05-25 | 东莞市朋志生物科技有限公司 | Anti-human igm antibody and preparation method therefor and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4792447A (en) * | 1981-07-23 | 1988-12-20 | Board Of Regents, The University Of Texas System | Anti-immunoglobulin toxin conjugates useful in the treatment of B cell tumors |
| WO1992007574A1 (en) * | 1990-10-25 | 1992-05-14 | Tanox Biosystems, Inc. | Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on b cells |
-
1991
- 1991-04-08 IE IE117291A patent/IE911172A1/en unknown
- 1991-04-10 NZ NZ237784A patent/NZ237784A/en unknown
- 1991-04-11 IL IL97827A patent/IL97827A0/en unknown
- 1991-04-11 ZA ZA912695A patent/ZA912695B/en unknown
- 1991-04-17 TW TW080103007A patent/TW349995B/en active
- 1991-04-24 RU RU92016351A patent/RU2105062C1/en active
- 1991-04-24 EP EP19910909436 patent/EP0538267A4/en not_active Withdrawn
- 1991-04-24 WO PCT/US1991/002822 patent/WO1991017257A1/en not_active Application Discontinuation
- 1991-04-24 JP JP3509144A patent/JPH06504424A/en active Pending
- 1991-04-24 CA CA002079901A patent/CA2079901A1/en not_active Abandoned
- 1991-04-26 PT PT97482A patent/PT97482B/en not_active IP Right Cessation
- 1991-04-27 CN CN91102913A patent/CN1057072A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2079901A1 (en) | 1991-10-28 |
| NZ237784A (en) | 1992-09-25 |
| TW349995B (en) | 1999-01-11 |
| EP0538267A1 (en) | 1993-04-28 |
| ZA912695B (en) | 1993-02-24 |
| PT97482A (en) | 1992-01-31 |
| PT97482B (en) | 1998-08-31 |
| IE911172A1 (en) | 1991-11-06 |
| AU7866491A (en) | 1991-11-27 |
| AU650659B2 (en) | 1994-06-30 |
| CN1057072A (en) | 1991-12-18 |
| RU2105062C1 (en) | 1998-02-20 |
| WO1991017257A1 (en) | 1991-11-14 |
| JPH06504424A (en) | 1994-05-26 |
| EP0538267A4 (en) | 1994-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0539970A3 (en) | Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby | |
| HU896763D0 (en) | Process for the preparation of bispecific monoclonal antibody | |
| EP0186833A3 (en) | A cytotoxic protein, a process for its isolation, a monoclonal antibody ct-1 and a hyrbridoma producing the same | |
| ZA887987B (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
| GB9112836D0 (en) | Production of monoclonal antibodies | |
| GB8910395D0 (en) | Human monoclonal antibody and hybridoma producing the same | |
| IL90017A0 (en) | Monoclonal antibodies | |
| HUT63205A (en) | Process for producing monoclonal antibodies and their fragments | |
| GB2158094B (en) | Anti-human igg monoclonal antibody and process for preparing the same | |
| ZA898777B (en) | Monoclonal antibodies | |
| GB9204928D0 (en) | Monoclonal antibody production | |
| IL92232A0 (en) | Anti-fucosylceramide monoclonal antibody | |
| IL97827A0 (en) | Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing them | |
| IL91649A0 (en) | Hybrid monoclonal antibodies,their production and use | |
| ZA89258B (en) | Monoclonal antibodies | |
| GB8927389D0 (en) | Monoclonal antibodies | |
| GB8820036D0 (en) | Monoclonal antibodies | |
| IL92312A0 (en) | Monoclonal antibody specifically recognizing n-glycolyl type gm2,hybridoma producing the antibody and method for preparing the hybridoma | |
| HUT62803A (en) | Process for producing antigen-specific, high affinity human monoclonal antibody | |
| ZA912136B (en) | Anti-oncostatin m monoclonal antibodies | |
| EP0446763A3 (en) | Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody | |
| IE900593L (en) | Monoclonal antibodies | |
| IE901210L (en) | Monoclonal antibody | |
| IE900922L (en) | Monoclonal antibody | |
| EP0336441A3 (en) | Anti-cpbii monoclonal antibody |